M ULTIPLE LINES OF experimental, epidemiological,
and clinical evidence support the notion that a crosstalk between the insulin receptor and G protein-coupled receptor (GPCR) signaling systems plays a critical role in the regulation of normal physiological functions as well as in the pathogenesis of a variety of abnormal processes (1) . For example, genetic disruption of the bradykinin B 2 receptor in diabetic Akita mice markedly increases the severity of the diabetic phenotype, implying that a crosstalk between insulin and bradykinin plays a critical role in normal homeostatic regulation (2, 3) . An important role of a crosstalk between insulin and angiotensin II (ANG II) in the pathogenesis of cardiovascular and renal pathologies in obesity, metabolic syndrome, and type II diabetes is increasingly recognized (2) (3) (4) (5) (6) and underscored by the clinical benefits of angiotensinconverting enzyme (ACE) inhibition in these conditions (7, 8) . Epidemiological studies have also linked hyperinsulinemia and type II diabetes with increased risk for developing a variety of clinically aggressive cancers of several tissues (9 -12) , including pancreatic ductal adenocarcinoma (13) (14) (15) , colon (16 -18) , and prostate (19) , and administration of ACE inhibitors protect against various cancers (20, 21) . Interestingly, many cancer cells, including human pancreatic adenocarcinoma cells, are known to express multiple functional GPCRs that mediate rapid signaling and mitogenesis in response to their corresponding agonists (22) (23) (24) (25) (26) (27) (28) , and, accordingly, GPCRs are increasingly implicated in autocrine/paracrine growth stimulation of cancer cells (29 -35) . It is plausible, therefore, that a crosstalk between insulin and GPCR signaling pathways could also exist in cancer cells.
The signaling pathways activated by either GPCR agonists or insulin have been the subject of intense scrutiny (8, 30, 31, 36 -38) . Many agonists, including ANG II and bradykinin, bind to their cognate heptahelical GPCRs and activate pertussis toxin (PTx)-insensitive G q , promoting its dissociation into G␣ q and G␤␥ and the exchange of GDP bound to G␣ q for GTP. The resulting GTP-G␣ q complex activates the ␤ isoforms of phospholipase C (PLC) via interaction with the carboxy-terminal region of the enzyme (39) . PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] to produce two-second messengers: inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ] and diacylglycerol (DAG). Ins(1,4,5)P 3 binds to its intracellular receptor, a ligand-gated Ca 2ϩ channel located in the endoplasmic reticulum (40) , and triggers the release of Ca 2ϩ from internal stores, leading to a rapid and transient increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), whereas DAG stimulates members of the protein kinase C (PKC) and D (PKD) families (30, (41) (42) (43) . Binding of insulin to its tetrameric receptor results in receptor autophosphorylation and activation of the receptor tyrosine kinase, followed by tyrosine phosphorylation of insulin receptor substrates that further propagate downstream signals (36, 44) . The phosphatidylinositol 3 (PI3)-kinase/ Akt/mTOR (mammalian target of rapamycin) signaling module is one of the major insulin-induced pathways. Recent evidence indicates that mTOR is a point of convergence of signals from mitogenic growth factors, nutrients, cellular energy levels, and stress conditions to stimulate protein synthesis and cell growth (45) . Despite the clinical and biological importance of the crosstalk between insulin receptor and GPCR signaling systems, especially those activated by the peptides regulated by ACE (ANG II and bradykinin), little is known about mechanisms by which insulin receptor activation rapidly modulates signaling through G q protein-coupled receptors (G q PCRs).
Using pancreatic adenocarcinoma cells that express multiple GPCRs as a model system, we report here that cell exposure to insulin rapidly and selectively increases the rate and magnitude of the increase in [Ca 2ϩ ] i elicited by multiple G q PCR agonists, including ANG II, bradykinin, bombesin, neurotensin, and vasopressin. Using real-time imaging of changes in PtdIns(4,5)P 2 hydrolysis and generation of Ins(1,4,5)P 3 in single cells, we found that treatment with insulin enhances the rate and magnitude of these secondmessenger-generating responses. Our results demonstrate that insulin-induced potentiation of G q PCR signaling is mediated through a rapamycin-sensitive, PI3-kinase/mTORdependent pathway.
Materials and Methods

Cell culture
In view of the phenotypic heterogeneity of pancreatic cancer cell lines manifested in different growth and differentiation patterns, oncogene, and GPCR expression (22) , the experiments presented here were performed in different pancreatic cell lines originated in different laboratories. The following human pancreatic cancer cell lines, obtained from American Type Culture Collection (Manassas, VA), were used: BxPc-3, HPAF-II, and PANC-1. BxPc-3 and PANC-1 are less well-differentiated cell lines, whereas HPAF-II is a well-differentiated cell line derived from a human pancreatic adenocarcinoma. Cells were grown in 10-cm tissue culture dishes in a 37 C incubator with a humidified atmosphere as follows: BxPc-3 and HPAF-II in 5% CO 2 , PANC-1 in 10% CO 2 . BxPc-3 and HPAF-II cells were grown in MEM (Invitrogen, Carlsbad, CA) supplemented with 0.1 mm MEM nonessential amino acids, antibiotics (100 U/ml penicillin plus 50 mg/ml streptomycin and gentamycin), and 10% fetal bovine serum (FBS). PANC-1 were grown in DMEM (Invitrogen) with 4 mm glutamine, 1 mm Na-pyruvate, antibiotics (100 U/ml penicillin plus 50 mg/ml streptomycin and gentamycin), and 10% FBS. To determine whether the results obtained in pancreatic cancer cells can replicated in cultures of nontumorigenic epithelial cells, we used intestinal crypt-derived IEC-18 cells, a cell line used in studies of GPCRinduced signal transduction (46 -48) . These cells were grown in DMEM (Invitrogen) with 4 mm glutamine, 1 mm Na-pyruvate, antibiotics (100 U/ml penicillin plus 50 mg/ml streptomycin and gentamycin), and 5% FBS.
Measurement of [Ca 2ϩ ] i
Cells grown on glass coverslips for 4 -5 d were washed in Hanks' balanced salt solution supplemented with 0.03% NaHCO 3 , 1.3 mm CaCl 2 , 0.5 mm MgCl 2 , 0.4 mm MgSO 4 , and 0.1% BSA (pH 7.4) (Hanks' buffer). After washing, cells were incubated with 5 m fura 2-tetraacetoxy methyl ester (fura 2-AME) from a stock of 1 mm in dimethylsulfoxide for 10 min in a 37 C incubator. Cells were then washed again with Hanks' buffer and left at room temperature for an additional 5 min. The fura-loaded cells were introduced in a cuvette containing the incubation medium (Hanks' buffer), and the cuvette was placed into a Hitachi (Tokyo, Japan) F-2000 fluorospectrophotometer. The incubation medium in the cuvette was continuously stirred at 37 C. The excitation wavelengths were set at 340 and 380 nm, and the emission wavelength was set at 510 nm. The maximum fluorescence was determined after membrane permeabilization by the addition of 37.5 m digitonin. The minimum fluorescence was measured after the Ca 2ϩ in the solution was chelated by the addition of EGTA at a final concentration of 25 mm. A K d of 224 nm was used for the Ca 2ϩ dissociation constant from fura 2 in the cells at 37 C. [Ca 2ϩ ] i was determined automatically by the cation measurement software of the F-2000 fluorospectrophotometer. Agonists and/or antagonists were added at various time points during recording, as indicated in the individual experiments.
Cell transfection
BxPc-3 cells were transfected with the plasmid containing a cDNA encoding a green fluorescent protein (GFP) tagged-pleckstrin homology domain (PHD) of human PLC-␦1 (GFP-PHD) (49) by using Lipofectin or Lipofectamine Plus (Invitrogen) as suggested by the manufacturer. Analysis of the cells transiently transfected were performed 24 h after transfection.
Real-time Ins(1,4,5)P 3 imaging in single live cells
Single live-cell imaging of the fluorescent biosensor for Ins(1,4,5)P 3 (GFP-PHD) was achieved with a fluorescence microscope. The plasmid encoding GFP-PHD was produced as described previously (49) . To maintain a constant temperature of 37 C during the experimental procedures, cells grown in the 15-mm glass coverslips were mounted in a RC-25 perfusion chamber (Warner Instruments, Hamden, CT) and perfused with medium preheated at 37 C by a TC-344B chamber system heater controller (Warner Instruments). The medium was supplemented with 10 mm HEPES (pH 7.2). The microscope used was a Zeiss (Oberkochen, Germany) epifluorescent Axioskop with a Zeiss Achroplan 40ϫ/0.75 water immersion objective (Zeiss). Images were captured as uncompressed 24-bit TIFF files with a SPOT cooled single CCD color digital camera driven by SPOT version 2.1 software (Diagnostic Instruments, Sterling Heights, MI). GFP fluorescence was observed with a HI Q filter set for fluorescein isothiocyanate (Chroma Technology, Rockingham, VT).
Live-cell imaging and quantitative analysis of the relative change in plasma membrane and cytosol fluorescence intensity of individual cells were performed using Sigmascan version 3.0 (SPSS, Chicago, IL) as described in our previous paper (49) . We analyzed 60 cells in each experiment, and each experiment was performed in at least triplicate. The selected cells displayed in the figures were representative of 90% of the population of positive cells.
Western blot analysis
Samples of cell lysates were directly solubilized by boiling in SDS-PAGE sample buffer [200 mm Tris-HCl (pH 6.8), 2 mm EDTA, 0.1 m Na 3 VO 4 , 6% SDS, 10% glycerol, and 4% 2-mercaptoethanol]. Proteins were resolved in SDS-10% PAGE and transferred to Immobilon-P membranes (Millipore, Billerica, MA), as described previously (26) , and blocked for 2 h with 5% nonfat dried milk in PBS (pH 7.2). Membranes were incubated overnight with a polyclonal antibody that detects the phosphorylated state of myristoylated alanine-rich C kinase substrate (MARCKS) at serine152/156 (Cell Signaling Technology, Danvers, MA) or anti-phospho-PKD-2 (serine 876) polyclonal antibody (Millipore) at a dilution of 1:1000 in PBS containing 3% nonfat dried milk and 0.5% Tween 20. Immunoreactive bands were visualized using horseradish peroxidase-conjugated antirabbit IgG and enhanced chemiluminescence (GE Healthcare Biosciences, Little Chalfont, Buckinghamshire, UK) detection. The same membranes were subsequently stripped and probed in a similar manner with anti-MARCKS (M-20) polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:500 and anti-PKC/PKD (C-20), which recognizes PKD and PKD2 (Santa Cruz Biotechnology) at a dilution of 1:1000 in PBS containing 5% nonfat dried milk and 0.1% Tween 20. Autoradiograms were scanned, and the labeled bands were quantified using the Quantity One software program (BioRad, Hercules, CA).
Statistical analysis
The values obtained are presented as the mean Ϯ sem and analyzed with Student's t test, using SigmaPlot 2000 (SPSS).
Materials
Bradykinin, ANG II, bombesin, neurotensin, and vasopressin were obtained from Sigma (St. Louis, MO). U0126 [1,4- 
, wortmannin, and rapamycin were from Calbiochem (La Jolla, CA). All other reagents were of the highest grade commercially available.
Results
Insulin potentiates Ca 2ϩ signaling by G q PCR agonists in human pancreatic adenocarcinoma cells
The mobilization of Ca 2ϩ from intracellular stores leading to a rapid and transient increase in [Ca 2ϩ ] i is one of the earliest events stimulated by agonist binding to GPCRs that signal through G␣ q -mediated activation of PLC. To determine whether insulin modulates GPCR-mediated increase in [Ca 2ϩ ] i , human pancreatic cancer BxPc-3 cells loaded with the fluorescent Ca 2ϩ indicator fura 2-AME were stimulated with the GPCR agonist bradykinin, and the changes in [Ca 2ϩ ] i were continuously recorded as described in Materials and Methods.
Addition of bradykinin (5 nm) to BxPc-3 cells induced a rapid increase in [Ca 2ϩ ] i from a basal level of 185 Ϯ 6 nm (mean Ϯ sem; n ϭ 122) to a peak value of 601 Ϯ 12 nm (n ϭ 120) at 25-35 sec, which subsequently declined toward a plateau phase (Fig. 1A) . Addition of insulin (10 ng/ml) to BxPc-3 cells did not produce any detectable change in [Ca 2ϩ ] i (Fig. 1A) . However, exposure of BxPc-3 cells to 10 ng/ml insulin for 5 min before their stimulation with bradykinin promoted a striking enhancement in [Ca 2ϩ ] i that reached a maximum peak of 1122 Ϯ 84 nm (n ϭ 109) (Fig. 1A) . The rate of [Ca 2ϩ ] i rise after the addition of bradykinin was markedly increased, implying that exposure to insulin also accelerates GPCR-elicited intracellular Ca 2ϩ mobilization (Fig. 1A) . To examine whether enhanced [Ca 2ϩ ] i mobilization in response to insulin could also be promoted by other G q PCR agonists, BxPc-3 cells were exposed to 10 ng/ml insulin for 5 min before their stimulation with either ANG II (100 nm) or vasopressin (100 nm). Similar to the results obtained with bradykinin, previous exposure to insulin enhanced both the peak and rate of the increase in [Ca 2ϩ ] i induced by ANG II or vasopressin (Fig. 1, B and C (Fig. 2A) . The potentiating effect of insulin could be detected at a concentration as low as 1 ng/ml (0.17 nm), with a half-maximal stimulatory concentration achieved at approximately 5 ng/ml (0.85 nm). Interestingly, these concentrations are in good agreement with the range of circulating insulin levels observed in fasting normal insulin-sensitive people (0.1 nm) and in subjects with insulin resistance and in type 2 diabetes (1.5 nm) (50). We also determined the length of time required by insulin to enhance the increase in [Ca 2ϩ ] i in response to G q PCR stimulation. Maximal potentiation of [Ca 2ϩ ] i by bradykinin or ANGII was achieved after 1-2 min of previous exposure to insulin (Fig.  2B ). Addition of 10 ng/ml insulin after cell stimulation with bradykinin did not produce any additional increase in [Ca 2ϩ ] i (results not shown).
We next determined whether insulin was also able to enhance Ca 2ϩ signaling in other ductal adenocarcinoma pancreatic cells. HPAF-II cells have been extensively used as a model system to study the effects of growth factors on the biological behavior of human pancreatic cancer cells (27) . HPAF-II tumors developed in either orthotopic or xenograft nude mice models closely resemble features of human pancreatic ductal adenocarcinoma (51) . As illustrated in Fig. 2C , exposure of HPAF-II to insulin for 5 min markedly enhanced the increase in [Ca 2ϩ ] i elicited by the GPCR agonists ANG II, bombesin, and neurotensin. Similarly, pretreatment with insulin markedly potentiated intracellular Ca 2ϩ mobilization in response to neurotensin in PANC-1 cells (Fig. 2D ). These results demonstrate that a brief exposure to insulin potentiates the ability of multiple GPCR agonists, including ANG, bombesin, bradykinin, neurotensin, and vasopressin, to elicit Ca 2ϩ signaling in BxPc-3, HPAF-II, and PANC-1 pancreatic adenocarcinoma cells.
Insulin selectively potentiates Ca 2ϩ signaling in response to G q PCR agonists
Because the results illustrated in Figs. 1 and 2 used GPCR agonists that bind to receptors coupled to G q , it was reasonable to hypothesize that insulin potentiates signaling through G q /PLC␤. As a first step to examine this hypothesis, we determined whether insulin potentiates Ca 2ϩ mobilization from internal stores in response to G q PCR agonists but fails to enhance Ca 2ϩ signaling produced by agents that either bypass receptor-mediated pathways or agonists that activate PLC through G i rather than G q .
Bradykinin increased [Ca 2ϩ ] i in BxPc-3 cells by two mechanisms: the initial peak resulted from Ca 2ϩ mobilization from intracellular stores because it still occurred after chelation of extracellular Ca 2ϩ with EGTA, whereas the plateau phase was mediated by the influx of extracellular Ca 2ϩ because it was greatly reduced by chelating extracellular Ca 2ϩ with EGTA. As shown in Fig. 3A , the increase in Ca 2ϩ signaling produced by insulin pretreatment was maintained after chelation of extracellular Ca 2ϩ with EGTA, indicating that insulin enhances bradykinin-induced mobilization of Ca 2ϩ from internal stores.
The tumor promoter thapsigargin has been identified as a specific inhibitor of the Ca 2ϩ ATPase pump of the endoplasmic reticulum, which is responsible for the accumulation of Ca 2ϩ into these stores (52) . Treatment of intact cells with thapsigargin induces mobilization of Ca 2ϩ from internal stores bypassing PLC-mediated formation of Ins(1,4,5)P 3 . In contrast to the effects obtained with GPCR agonists, the increase in [Ca 2ϩ ] i induced by addition of 1 m thapsigargin to BxPc3 cells was not altered by previous exposure to insulin, indicating that insulin potentiates Ca 2ϩ mobilization from internal stores produced through receptor-mediated pathways (data not shown).
Lysophosphatidic In contrast to the results obtained when BxPc-3 cells were challenged with G q PCR agonists, pretreatment with 10 ng/ml insulin for 5 min failed to potentiate the [Ca 2ϩ ] i response induced by LPA (Fig. 3C) . Furthermore, pretreatment of BxPc-3 cells with different concentrations of insulin (1-1000 ng/ml) for 5 min (Fig. 3D) or with a fixed concentration of insulin (10 ng/ml) for different times ( ] i started to increase. The panels with bradykinin represent 20 independent experiments (summarized n ϭ 122 for bradykinin; n ϭ 109 for bradykinin after insulin pretreatment), and the panels with ANG II and vasopressin represent at least five independent experiments for each agonist (n ϭ 35 for ANG II, n ϭ 40 for ANG II after insulin pretreatment; n ϭ 32 for vasopressin and n ϭ 36 for vasopressin after insulin pretreatment). The results shown are the mean Ϯ SEM and compared with the control (absence of insulin pretreatment). **, P Ͻ 0.01. insulin concentration tested. These results indicate that insulin does not potentiate Ca 2ϩ mobilization elicited by agonists that act through this G i -stimulated pathway.
Insulin potentiates bradykinin-induced Ins(1,4,5)P 3 synthesis in BxPc-3 cells
Ins (1,4,5)P 3 is one of the best characterized second messengers that triggers the release of Ca 2ϩ from internal stores in response to agonists that stimulate G q /PLC␤. Accordingly, we determined whether insulin receptor signaling potentiates the ability of G q PCRs to stimulate the synthesis of Ins(1,4,5)P 3 by examining the dynamic distribution of a fusion protein between GFP and the PHD of human PLC-␦1 (GFP-PHD). This PHD binds PtdIns(4,5)P 2 in the plasma membrane but translocates to the cytosol in response to PLCmediated Ins(1,4,5)P 3 synthesis (49, 53, 54) .
Before GPCR stimulation, GFP-PHD was predominantly localized at the plasma membrane (n ϭ 122) of BxPc-3 cells (Fig. 4A, arrows) , whereas GFP was localized throughout the cell (data not shown). Bradykinin stimulation induced a time-dependent translocation of GFP-PHD from the plasma membrane to the cytoplasm (n ϭ 62) (Fig. 4B) , reflecting PtdIns(4,5)P 2 hydrolysis and production of Ins(1,4,5)P 3 . Although pretreatment with 10 ng/ml insulin for 5 min failed to promote plasma membrane dissociation of GFP-PDH (Fig.  4C , 0 sec), bradykinin stimulation of insulin-pretreated cells caused a very rapid plasma membrane dissociation and cytoplasmic translocation of GFP-PDH (Fig. 4C ). Quantitative analysis of the dynamic distribution of GFP-PDH shows that exposure of the cells to insulin before bradykinin stimulation promotes within 10 sec the translocation of GFP-PHD from the plasma membrane to the cytosol (Fig. 4D) . Furthermore, previous exposure to insulin significantly increased the extent of plasma membrane dissociation of the Ins(1,4,5)P 3
Insulin (ng/ml) sensor (Fig. 4, compare B and D) . These results indicate that cell exposure to insulin before bradykinin increased the rate and extent of PLC-mediated PtdIns(4,5)P 2 hydrolysis and production of Ins(1,4,5)P 3 .
Insulin potentiates bradykinin-induced MARCKS phosphorylation and PKD2 activation in BxPc-3 cells
DAG, the other product of PLC-catalyzed hydrolysis of PtdIns(4,5)P 2 , stimulates novel PKCs and, in conjunction with Ca 2ϩ , conventional PKCs. The PKCs directly phosphorylate MARCKS, whose phosphorylation is used as a marker of PKC activation within the cell (55, 56) . To substantiate that insulin potentiates PLC-mediated PtdIns(4,5)P 2 hydrolysis, we determined whether insulin enhances bradykinin-induced PKC-dependent phosphorylation of MARCKS in BxPc-3 cells. As shown in Fig. 5A , stimulation of these cells with bradykinin for 30 sec markedly increased MARKCS phosphorylation at Ser-152/Ser-156. In BxPc-3 cells treated with 10 ng/ml insulin for 5 min, bradykinin elicited MARKS phosphorylation as early as 15 sec after its addition (Fig. 5A) , and its stimulatory effect on MARCKS phosphorylation at 30 sec was further enhanced by previous exposure to insulin, supporting the notion that insulin potentiates G q PCR signaling.
The PKD family of serine/threonine protein kinases comprising PKD, PKD2, and PKD3 occupies a unique position in the signal transduction pathways initiated by DAG and PKC. PKDs not only are direct DAG targets but also are downstream of PKCs in a novel signal transduction pathway implicated in the regulation of multiple fundamental biological ] i increase. BxPc-3 cells were pretreated with 100 ng/ml PTx (thick traces) or vehicle (thin traces) for 3 h and then stimulated with 500 nM LPA. The tracings are representative of three independent experiments, each performed at least in triplicate. C, Exposure to insulin does not enhance Ca 2ϩ signaling in response to LPA. BxPc-3 cells were treated without (open bars) or with (filled bars) 10 ng/ml insulin for 5 min and then challenged with 500 nM LPA. The results shown are the mean Ϯ SEM of at least three independent experiments (n ϭ 15 for LPA; n ϭ 21 for LPA after insulin pretreatment). D, Exposure to increasing concentrations of insulin does not enhance Ca 2ϩ signaling in response to LPA. BxPc-3 cells were treated with increasing concentrations of insulin for 5 min and then stimulated with 500 nM LPA. E, Exposure to insulin for various times does not enhance Ca 2ϩ signaling in response to LPA. BxPc-3 cells were treated with 10 ng/ml insulin for increasing lengths of time (2.5 sec to 5 min). Then, the cells were stimulated with 500 nM LPA. Each point is representative of at least three independent experiments performed in triplicate.
processes (for review, see Ref. 43 ). The major isoform of PKD expressed by BxPc-3 cells is PKD2 (data not shown). The antibody specifically recognizing the phosphorylated form of a PKD2 C-terminal residue, Ser-876, detects in vivo autophosphorylation. As shown in Fig. 5B , bradykinin stimulation of BxPc-3 cells induced PKD2 phosphorylation at Ser-876 at both 15 and 30 sec. Treatment of these cells with 10 ng/ml insulin for 5 min enhanced PKD2 activation in response to bradykinin. The results obtained with MARCKS and PKD2 support the hypothesis that insulin receptor stimulation potentiates G q PCR signaling, leading to an increase in the production of the second messengers generated by PLC-mediated PtdIns(4,5)P 2 hydrolysis.
The PI3-kinase/mTOR pathway mediates the insulininduced potentiation of Ca 2ϩ signaling and PtdIns(4,5)P 2 hydrolysis produced by G q PCR agonists
To determine the mechanism by which insulin leads to enhanced PLC-mediated PtdIns(4,5)P 2 hydrolysis, production of Ins(1,4,5)P 3 , and Ca 2ϩ signaling in response to G q PCR agonists, we determined the role of PI3-kinase/mTOR, a major insulin-induced pathway (36, 44) . BxPc-3 cells were incubated with or without the selective inhibitors of PI3-kinase LY-294002 and wortmannin or with rapamycin, a selective inhibitor of mTOR in complex with the protein raptor (45, 57) . Then, the treated cells were incubated or not with insulin and subsequently challenged with bradykinin. As seen in Fig. 6A , treatment of BxPc-3 cells with LY-294002, wortmannin, or rapamycin did not have any detectable effect on the increase in [Ca 2ϩ ] i induced by bradykinin but completely abolished the enhancement of Ca 2ϩ signaling produced by previous exposure to insulin. We found that treatment with 10 nm rapamycin for only 10 min before the addition of insulin was sufficient to abolish insulin-induced enhancement of Ca 2ϩ signaling (results not shown). In contrast, exposure to U0126, an inhibitor of MAPK kinase (MEK) 1, MEK2, and the closely related MEK5 (58), did not affect insulin-induced potentiation of bradykinin-elicited Ca 2ϩ signaling.
The role of the PI3-kinase/mTOR signaling in mediating insulin-induced potentiation of Ca 2ϩ signaling in response to the GPCR agonists was also demonstrated in PANC-1 cells stimulated with neurotensin (Fig. 6B) . Specifically, treatment with either LY-294002 or rapamycin blocked the potentiation of Ca 2ϩ signaling induced by insulin in PANC-1 cells challenged with the G q PCR agonist neurotensin.
To determine whether suppression of the PI3-kinase/Akt/ mTOR also prevents the increase in the rate and extent of GPCR-induced hydrolysis of PtdIns(4,5)P 2 produced by exposure to insulin, we monitored the distribution of the biosensor for PtdIns(4,5)P 2 generation, GFP-PHD. LY-294002 or rapamycin delayed the redistribution of GFP-PHD from the plasma membrane to the cytosol after bradykinin stimulation in insulin-pretreated BxPc-3 cells (Fig. 6C) . In the presence of these inhibitors, bradykinin-induced synthesis of Ins(1,4,5)P 3 in cells exposed to insulin was identical to that seen in control cells (Fig. 6D) .
Insulin potentiates Ca 2ϩ signaling in response to ANG II and vasopressin in normal intestinal epithelial IEC-18 cells
We next determined whether the ability of insulin to potentiate G q signaling through an mTOR-dependent pathway could be demonstrated in normal as well as in cancer cells, using normal crypt-derived intestinal epithelial IEC-18 cells. Stimulation of these cells with either ANG II or vasopressin elicits Ca 2ϩ signaling and PKC/PKD activation (46 -48, 59 -61), providing an additional model system to examine crosstalk between insulin receptor and GPCR signaling systems.
Similar to the results obtained with pancreatic cancer cells, exposure of IEC-18 cells to insulin (10 ng/ml for 5 min) markedly enhanced the peak and the rate of increase in [Ca 2ϩ ] i induced by a subsequent stimulation with either ANG II (Fig. 7A) or vasopressin (Fig. 7B) . Treatment with LY-294002 completely abrogated and rapamycin markedly attenuated the potentiation of Ca 2ϩ signaling induced by The cells were then washed in cold PBS, lysed in 2ϫ SDS-PAGE sample buffer, were run in an SDS-10% PAGE, and then transferred to Immobilon membranes, as indicated in Materials and Methods. Samples were analyzed for MARCKS phosphorylation at Ser-152/156 (pMARCKS) using a specific antibody that detects the phosphorylated state of these residues (A). Parallel membranes were analyzed by Western blotting using MARKCS (M-20) antibody to verify equal loading. Shown here is a representative autoluminogram. Graphed data (right) represents mean values (mean Ϯ SEM; n ϭ 9 -10) of the level of MARCKS phosphorylation obtained from scanning densitometry. Control, Gray bars; insulin alone, striped bars; bradykinin without insulin pretreatment, white bars; bradykinin with insulin pretreatment, black bars. Samples were analyzed for PKD2 autophosphorylation at Ser-876 (pPKD2) using a specific antibody that detects the phosphorylated state of this residue (B). Parallel membranes were analyzed by Western blotting using PKC/PKD (C-20) antibody to verify equal loading. Shown here is a representative autoluminogram. Graphed data (right) represents mean values (mean Ϯ SEM; n ϭ 9) of the level of PKD2 autophosphorylation obtained from scanning densitometry. Control, Gray bars; insulin alone, striped bars; bradykinin without insulin pretreatment, white bars; bradykinin with insulin pretreatment, black bars. *, P Ͻ 0.05 and **, P Ͻ 0.01, statistical significances in the comparison of the effect of insulin with the corresponding bradykinin alone treatment.
insulin in IEC-18 cells challenged with the G q PCR agonist vasopressin (Fig. 7C) . These results indicate that the crosstalk between insulin and G q PCR agonists identified in this study is not restricted to cancer cells but can be demonstrated in nontumorigenic cell model systems.
Discussion
In an effort to elucidate the mechanism(s) underlying the crosstalk between insulin receptor and GPCR signaling systems, we examined whether cell exposure to insulin can rapidly modulate the magnitude and/or duration of early signals elicited by GPCR activation. The results presented in this study Thus, our results indicate that insulin enhances signaling triggered by multiple GPCR agonists, including ANG II, in pancreatic and intestinal cell model systems. Interestingly, previous studies examining the effect of ANG II on insulin (i.e. the opposite crosstalk to that studied in this paper) demonstrated inhibitory effects of ANG II on insulin signaling (1, 8, 62) and suggested that ANG II contributes to insulin resistance. It is conceivable that the stimulatory effect of insulin on G q PCR signaling (the results in this manuscript) and the inhibitory effects of ANG II on insulin signaling (1, 8, 62) are components of a pathogenic mechanism that promotes peripheral insulin resistance and hyperinsulinemia and eventually leads to ␤-cell failure. The examination of this hypothesis warrants additional experimental work using a variety of insulin-sensitive cell types.
We produced several lines of evidence indicating that insulin enhances PLC-mediated PtdIns(4,5)P 2 hydrolysis, production of Ins(1,4,5)P 3 , Ca 2ϩ mobilization from internal stores, and DAG-stimulated PKC elicited by G q PCRs: 1) cell exposure to insulin enhanced Ca 2ϩ signaling in response to activation of multiple G q PCRs, including those recognizing the biologically active peptides ANG II, bradykinin, bombesin, neurotensin, and vasopressin; 2) insulin did not increase Ca 2ϩ signaling by thapsigargin, an agent that bypasses receptor-mediated pathways and directly discharges internal pools; 3) insulin did not augment Ca 2ϩ signaling in response to LPA, a GPCR agonist that increases [Ca 2ϩ ] i through a PTx-sensitive G i signaling pathway rather than via G q in pancreatic cancer cells; 4) using a fusion protein between GFP and the PH domain of PLC␦1, a sensor of PLC-mediated Ins(1,4,5)P 3 synthesis (49, 53, 54) , we demonstrated that exposure to insulin increased the rate and extent of Ins(1,4,5)P 3 production induced by bradykinin; and 5) cell exposure to insulin enhanced bradykinin-induced MARCKS phosphor- ylation and PKD2 activation. Collectively, these results provide strong support for the notion that exposure to insulin potentiates early signaling steps in G q PCR action.
As a first step to elucidate the mechanism(s) by which insulin potentiates G q PCR signaling, we attempted to identify the signaling pathway involved in insulin-induced potentiation of GPCR signaling. A major pathway stimulated by activation of the insulin receptor is the PI3-kinase/Akt/mTOR module. Recent evidence indicates that mTOR is a major point of convergence of signals from mitogenic growth factors, nutrients, cellular energy levels, and stress conditions to stimulate protein synthesis and cell growth (45) . Interestingly, two distinct TOR complexes, TORC1 and TORC2, have been characterized. TORC1 is sensitive to rapamycin and is responsible for phosphorylation of p70S6K and 4EBP1. In contrast, TORC2 is not inhibited by rapamycin (45, 57) . Our results show that shortterm treatment with either rapamycin or the PI3-kinase inhibitors LY-294002 and wortmannin completely abrogated the ability of insulin to increase the rate and magnitude of Ca 2ϩ signaling and production of Ins(1,4,5)P 3 in response to GPCR activation in pancreatic cancer cells. Our results also show that treatment with rapamycin or LY-294002 prevented the ability of insulin to increase Ca 2ϩ signaling in response to GPCR activation in normal intestinal epithelial IEC-18 cells. These results indicate, for the first time, that insulin potentiates G q /PLC signaling through a TORC1-dependent pathway in a variety of cell model systems.
Although our results show that cell exposure to insulin markedly enhanced subsequent GPCR-induced Ca 2ϩ signaling, we also found that the addition of these ligands in reverse order, i.e. addition of insulin after GPCR agonists, did not produce any additional increase in [Ca 2ϩ ] i . In this context, recent studies demonstrated that an elevation in [Ca 2ϩ ] i negatively regulates mTOR through tuberous sclerosis complex 2 phosphorylation via the AMP-activated protein kinase pathway (63) (64) (65) . Thus, an increase in the activity of the Ca 2ϩ /AMP-activated protein kinase pathway could act as a feedback mechanism that prevents excessive (potentially toxic) G q PCR-induced increases in [Ca 2ϩ ] i in cells receiving a concomitant insulin signal.
It is increasingly recognized that the crosstalk between insulin and GPCR signaling is critical for the regulation of multiple physiological functions and underlies the pathogenesis of important diseases, including cancer (for references, see introductory section). In this context, the incidence of obesity, metabolic syndrome, hypertension, and type II diabetes mellitus, characterized by insulin resistance and compensatory hyperinsulinemia, is reaching alarming rates in the developed world (10, 11, 66, 67) . Our results, identifying a crosstalk mechanism by which insulin potentiates Ca 2ϩ mobilization from internal stores and PKC/PKD activation in response to G q PCR activation, have, therefore, important implications. The magnitude, rate, and duration of increases in [Ca 2ϩ ] i are increasingly recognized as encoding critical information for a variety of biological processes, including secretion, differential gene expression, and cell proliferation (42) . Given the close relationship between the endocrine and exocrine pancreas through the insuloacinar portal system (68) and the local production of ANG II in the pancreas (69) , the crosstalk between insulin and G q PCRs is of especial significance for acinar and ductal pancreatic cells, but it is likely to be of importance for other cell types in the organism, in particular in states characterized by hyperinsulinemia. In view of the importance of gastrointestinal hormones in the function of intestinal epithelial cells (70) and the association between hyperinsulinemia and colon cancer (16 -18) , it is of interest that insulin also enhanced Ca 2ϩ signaling in response to G q PCR agonists in intestinal epithelial cells.
In conclusion, we propose that the potentiation of GPCR signaling by insulin through a TORC1-dependent pathway provides a mechanism by which insulin enhances the responsiveness of many cells and tissues to G q PCR agonists, including G q PCR-mediated autocrine and paracrine loops in cancer cells.
